Clinical trial

AC-OLE-01-VA Tolerability Study in Healthy Participants Under Different Dosing Conditions

NCT05628636

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2022-11-14

PhasePHASE1

Study timeline

Study start (actual)2022-11-14Date precision: day

Registry last updated2023-10-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Alzheimer Diseaseunresolved

Interventions

AC-OLE-01-VADRUG

Sponsors & collaborators

Cerecinlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05628636 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.